# Career
10 Mar
The Future of Biologics and Biosimilars: Patent Perspectives
The pharmaceutical industry is experiencing a significant transformation with the rapid growth of biologics and biosimilars. Biologics complex medicines derived from living organisms have revolutionized the treatment of diseases such as cancer, autoimmune disorders, and rare genetic conditions. As many blockbuster biologics approach patent expiration, biosimilars are emerging as cost-effective alternatives, reshaping the competitive landscape. […]
09 Mar
The Role of Competitive Intelligence in Pharmaceutical Innovation
The pharmaceutical industry is one of the most research-intensive and competitive sectors in the world. Companies invest billions of dollars in research and development to discover new therapies, improve existing drugs, and bring innovative treatments to market. In such a dynamic landscape, competitive intelligence (CI) has become a critical tool that helps pharmaceutical companies stay […]
06 Mar
Patent Landscape Analysis of Emerging Robotics Technologies
Introduction The robotics industry is experiencing rapid technological growth driven by advancements in artificial intelligence (AI), machine learning, sensors, and automation systems. From industrial manufacturing to healthcare and logistics, robotics technologies are transforming the way businesses operate and deliver services. As innovation accelerates, patent landscape analysis has become an essential tool for organizations seeking to […]
05 Mar
How 5G and Beyond Are Shaping the Future of Connectivity
Introduction The global telecommunications landscape is undergoing a transformative shift with the rollout of fifth-generation (5G) networks and the exploration of technologies that will define connectivity beyond 5G. As the demand for faster speeds, lower latency, and seamless digital experiences grows, telecommunications providers, technology companies, and governments worldwide are investing heavily in next-generation network infrastructure. […]
03 Mar
Role of Big Data in Consumer Behavior Analysis
In today’s hyper-competitive marketplace, understanding consumer behavior is no longer optional—it is a strategic necessity. The rise of digital commerce, omnichannel retailing, and real-time engagement platforms has generated massive volumes of consumer data. This is where Big Data plays a transformative role in decoding purchasing patterns, preferences, motivations, and future buying intent. For FMCG companies […]
02 Mar
Plastic Alternatives: Paper, PHA, PLA & Bio-Based Polymers
🌱 Plastic Alternatives: Paper, PHA, PLA & Bio-Based Polymers A Strategic View of Sustainable Materials Transforming the Packaging Industry 4 As sustainability regulations tighten and consumer demand for eco-friendly products accelerates, industries are actively shifting away from conventional petroleum-based plastics. Materials such as paper, PHA, PLA, and other bio-based polymers are emerging as viable […]
02 Mar
Invalidity & Opposition Trends in Biotech Patents
Introduction The biotechnology sector has evolved into one of the most patent-intensive industries in the global innovation economy. From gene-editing breakthroughs to monoclonal antibodies and cell-based therapies, biotech companies rely heavily on strong patent protection to justify massive R&D investments. However, as innovation accelerates, so does litigation. In recent years, invalidity challenges and opposition proceedings […]
27 Feb
Global Chemical Regulations: REACH, TSCA & Emerging Compliance Trends 2026 Overview
The global landscape for chemical regulation is rapidly evolving as governments, industry groups, and civil society respond to heightened concerns over health, environment, and sustainability. Two of the most influential regulatory frameworks — the EU’s REACH and the U.S. Toxic Substances Control Act (TSCA) — remain at the center of this evolution, while emerging trends […]
27 Feb
Biobased & Renewable Chemicals: Market Growth and Patent Landscape
Biobased & Renewable Chemicals: Market Growth and Patent Landscape Executive summary The global shift from fossil feedstocks to biomass-derived molecules is moving from niche R&D to industrial scale. Driven by policy incentives, corporate sustainability targets, technology advances in fermentation and biocatalysis, and growing consumer demand for circular products, the biobased chemicals sector is entering […]
26 Feb
Freedom-to-Operate Risks Rise in CRISPR & Gene Therapy Patents
Navigating IP Minefields in the Next Wave of Genetic Medicine Introduction: Innovation Meets the Patent Wall CRISPR gene editing and advanced gene therapies are no longer futuristic concepts—they are rapidly becoming mainstream tools in modern medicine. From one-time curative therapies for rare genetic disorders to next-generation oncology treatments, the promise of genetic medicine is transforming […]